Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.

AIDS

aInstitut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS), INSERM, Sorbonne Universités, Pierre-and-Marie-Curie University bDepartment of Virology, Hôpital Pitié-Salpêtrière cNeurological Intensive Care Unit, Neurology Department, Paris dInfectious and Tropical Diseases Department, Groupe Hospitalier Pitié Salpêtrière, Paris-Sorbonne Universités, Université Pierre et Marie Curie eINSERM, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, University of Paris-Sud fDepartment of Virology, CHU de Rennes, IRSET-INSERM, Université Rennes, Rennes gInstitut Pasteur, Hepatology Service, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Cochin Port-Royal, Université Paris Descartes, Sorbonne Paris Cité hUMRS CR7, CIMI-Paris, PVI Team, INSERM, Université Pierre et Marie Curie, Sorbonne Universités iPharmaco-Toxicology Department, IAME, Bichat-Claude Bernard Hospital , Université Paris Diderot, Sorbonne Paris Cité jInstitute of Cardiometabolism and Nutrition (ICAN), UMR, Groupe Hospitalier Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Sorbonne Universités kUMR, INSERM, Clamart, Paris, France.

Published: June 2017

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001474DOI Listing

Publication Analysis

Top Keywords

chronic hepatitis
4
hepatitis hiv/hbv
4
hiv/hbv coinfected
4
coinfected patient
4
patient lack
4
lack power
4
power sofosbuvir-ribavirin
4
chronic
1
hiv/hbv
1
coinfected
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!